Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
SMS Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:532815NSE Symbol: SMSPHARMAP/E(TTM):32.67
ISIN Demat:INE812G01025Div & Yield %:0.16EPS(TTM):7.71
Book Value(Rs):75.9221422Market Cap ( Cr.):2233.14Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 752.35554.56555.34611.60453.32511.47
Excise Duty43.0832.5135.4748.4341.3746.56
Net Sales709.27522.05519.87563.17411.95464.91
Other Income 4.464.915.203.455.113.40
Stock Adjustments 1.00-36.08112.50-26.7313.1414.48
Total Income714.73490.88637.57539.89430.20482.79
EXPENDITURE :      
Raw Materials 425.04299.52387.80313.27259.50307.19
Power & Fuel Cost47.1235.9732.5823.3118.9921.75
Employee Cost 56.7850.0851.0241.1739.3535.59
Other Manufacturing Expenses 26.5217.8622.6316.1914.8613.19
Selling and Administration Expenses 35.6825.2821.1219.0210.189.84
Miscellaneous Expenses 2.142.512.462.342.181.69
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure593.28431.23517.61415.31345.06389.25
Operating Profit121.4559.65119.97124.5985.1493.55
Interest 23.6021.9719.1611.1912.3211.92
Gross Profit97.8537.68100.81113.4072.8281.63
Depreciation31.5232.1332.1522.2822.0719.27
Profit Before Tax66.335.5568.6691.1250.7562.36
Tax15.130.0014.9216.058.9413.33
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.781.47-14.3014.119.137.57
Reported Net Profit49.424.0868.0460.9632.6941.45
Extraordinary Items 0.03-0.040.00-0.01-0.030.00
Adjusted Net Profit49.394.1268.0460.9732.7241.45
Adjst. below Net Profit -0.07-0.210.04-0.16-0.09-0.08
P & L Balance brought forward322.22320.88265.35214.55197.05168.23
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 12.542.5412.5410.0015.1012.55
P & L Balance carried down359.04322.22320.88265.35214.55197.05
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %40.0030.0030.0030.0025.0025.00
Earnings Per Share-Unit Curr5.840.488.047.203.864.90
Earnings Per Share(Adj)-Unit Curr5.840.488.047.203.864.90
Book Value-Unit Curr64.0258.4958.3350.5943.4040.16